Witte Jan De (Director) sold ~$102K of ResMed|
Planned saleWant the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
RMD · NYSE · Health Care Equipment
ResMed| (RMD) · oqro.io/stocks/RMD · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$236.88−5.73 (−2.36%)
Close of Nov 19, 2026, vs Nov 18 · end-of-day, not a live quote
Including 62 routine filings (option exercises, tax withholding, grants, gifts). Open-market trades only
Witte Jan De (Director) sold ~$102K of ResMed|
Planned saleDe Witte Jan (Director) plans to sell ~$102K of ResMed|
Planned, from payTraded Nov 11, 2026 · largest single transaction ~$170K
Nov 11, 2026724.41 · @ $234.11
DetailsOfficial recordInsider filing
Traded Nov 11 · filed 2 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Nov 11 · filed 2 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Nov 11 · filed 2 days later
Routine share withholding; mechanical by default.
Traded Nov 11, 2026 · largest single transaction ~$811K
Nov 11, 20263,465.75 · @ $234.11
DetailsOfficial recordInsider filing
Traded Nov 11 · filed 2 days later
Routine share withholding; mechanical by default.
Michael J. Farrell (Chairman and CEO) sold ~$1.18M of ResMed|
Planned saleTraded Nov 9, 2026 · largest single transaction ~$631K
Nov 9, 2026683
DetailsOfficial recordMichael J. Farrell (Officer) plans to sell ~$1.18M of ResMed|
Planned, from payMichael J Rider (Global General Counsel) sold ~$102K of ResMed|
Planned saleMichael J. Rider (Officer) plans to sell ~$102K of ResMed|
Planned, from payMichael J. Farrell (Chairman and CEO) sold ~$1.13M of ResMed|
Planned saleTraded Oct 7, 2026 · largest single transaction ~$730K
Oct 7, 20264,991 · @ $146.34
DetailsOfficial recordMichael J. Farrell (Officer) plans to sell ~$1.13M of ResMed|
Planned, from payInsider filing
Traded Aug 14 · filed 49 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Aug 14 · filed 49 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Aug 14 · filed 49 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Aug 14 · filed 49 days later
Compensation award — excluded from discretionary-purchase analysis.
Michael J. Farrell (Chairman and CEO) sold ~$1.11M of ResMed|
Planned saleTraded Sep 8, 2026 · largest single transaction ~$730K
Sep 8, 20264,991 · @ $146.34
DetailsOfficial recordMichael J. Farrell (Officer) plans to sell ~$1.13M of ResMed|
Planned, from payPeter C Farrell (Director) sold ~$228K of ResMed|
Planned salePeter C Farrell (Director) plans to sell ~$228K of ResMed|
Planned, from payMichael J. Farrell (Chairman and CEO) sold ~$1.03M of ResMed|
Planned saleTraded Aug 7, 2026 · largest single transaction ~$730K
Aug 7, 20264,991
DetailsOfficial recordPeter C Farrell (Director) sold ~$1.8M of ResMed|
Planned saleMichael J. Farrell (Chairman and CEO) sold ~$1.09M of ResMed|
Planned saleNov 11, 2026172.99 · @ $234.11
Nov 11, 2026547.47 · @ $234.11
DetailsOfficial recordNov 11, 2026498.62 · @ $234.11
DetailsOfficial recordNov 11, 20262,209.79 · @ $234.11
Nov 11, 20262,435.84 · @ $234.11
DetailsOfficial recordNov 9, 20264,310 · @ $146.34
DetailsOfficial recordNov 9, 20264,310
DetailsOfficial recordOct 7, 20264,991
Sep 8, 20264,991
0 open-market purchases and 14 open-market sales by insiders of RMD between Mar 31, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Oct 29, 2026. The data provider lists the next release for Jan 27, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Oct 29, 2026 | 2 sales | None | 2 sales |
| Aug 6, 2026 | 2 sales | None | 2 sales |
| Jul 7, 2026 | 1 sale | 1 sale | 1 sale |
| Apr 30, 2026 | 3 sales | None | 1 sale |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies